Concerning immunochemotherapy, inhibition of PD-1 on CD8+-tumor-infiltrating lymphocytes restored cytokine secretion and T cell proliferation and rendered tumor cells more sensitive to chemotherapy[61]. Here, CD8A is linked to neoplasm.